Green Street Investors LLC Sells 36,500 Shares of Sabra Health Care REIT Inc (NASDAQ:SBRA)

Share on StockTwits

Green Street Investors LLC trimmed its holdings in shares of Sabra Health Care REIT Inc (NASDAQ:SBRA) by 13.7% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 230,800 shares of the real estate investment trust’s stock after selling 36,500 shares during the quarter. Sabra Health Care REIT makes up about 2.9% of Green Street Investors LLC’s investment portfolio, making the stock its 14th largest holding. Green Street Investors LLC owned approximately 0.13% of Sabra Health Care REIT worth $4,544,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also made changes to their positions in SBRA. Swiss National Bank lifted its holdings in Sabra Health Care REIT by 2.1% in the 2nd quarter. Swiss National Bank now owns 331,741 shares of the real estate investment trust’s stock valued at $6,532,000 after purchasing an additional 6,800 shares in the last quarter. Envestnet Asset Management Inc. raised its holdings in shares of Sabra Health Care REIT by 47.9% during the 2nd quarter. Envestnet Asset Management Inc. now owns 49,923 shares of the real estate investment trust’s stock worth $983,000 after acquiring an additional 16,160 shares during the period. Candriam Luxembourg S.C.A. purchased a new stake in Sabra Health Care REIT in the 2nd quarter valued at about $470,000. Advisory Services Network LLC raised its holdings in Sabra Health Care REIT by 61.6% in the 2nd quarter. Advisory Services Network LLC now owns 18,852 shares of the real estate investment trust’s stock valued at $371,000 after buying an additional 7,189 shares during the period. Finally, Westpac Banking Corp raised its holdings in Sabra Health Care REIT by 98.5% in the 2nd quarter. Westpac Banking Corp now owns 360,445 shares of the real estate investment trust’s stock valued at $7,097,000 after buying an additional 178,837 shares during the period. Institutional investors own 88.01% of the company’s stock.

A number of equities analysts have recently commented on the company. TheStreet raised Sabra Health Care REIT from a “c+” rating to a “b” rating in a research report on Thursday, August 8th. Zacks Investment Research upgraded Sabra Health Care REIT from a “hold” rating to a “buy” rating and set a $24.00 price objective for the company in a research note on Thursday. Finally, BidaskClub upgraded Sabra Health Care REIT from a “buy” rating to a “strong-buy” rating in a research note on Saturday, August 10th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating, one has given a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $20.20.

Shares of Sabra Health Care REIT stock traded up $0.34 during trading hours on Thursday, hitting $21.99. 39,739 shares of the company were exchanged, compared to its average volume of 1,571,212. Sabra Health Care REIT Inc has a 1 year low of $15.70 and a 1 year high of $23.83. The company has a current ratio of 1.68, a quick ratio of 1.68 and a debt-to-equity ratio of 0.82. The business has a 50-day moving average of $20.72 and a 200-day moving average of $19.68. The stock has a market capitalization of $4.10 billion, a price-to-earnings ratio of 9.60, a P/E/G ratio of 12.13 and a beta of 0.89.

Sabra Health Care REIT (NASDAQ:SBRA) last released its quarterly earnings results on Wednesday, August 7th. The real estate investment trust reported $0.46 EPS for the quarter, missing the Thomson Reuters’ consensus estimate of $0.47 by ($0.01). Sabra Health Care REIT had a return on equity of 0.67% and a net margin of 3.37%. The company had revenue of $219.37 million for the quarter, compared to analysts’ expectations of $162.17 million. As a group, research analysts anticipate that Sabra Health Care REIT Inc will post 1.87 earnings per share for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, August 30th. Investors of record on Tuesday, August 20th will be paid a dividend of $0.45 per share. This represents a $1.80 dividend on an annualized basis and a dividend yield of 8.19%. The ex-dividend date of this dividend is Monday, August 19th. Sabra Health Care REIT’s payout ratio is currently 78.60%.

In related news, Director Michael J. Foster sold 15,000 shares of the stock in a transaction dated Wednesday, August 14th. The stock was sold at an average price of $20.78, for a total transaction of $311,700.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. 1.20% of the stock is owned by company insiders.

About Sabra Health Care REIT

As of December 31, 2018, Sabra's investment portfolio included 470 real estate properties held for investment (consisting of (i) 335 Skilled Nursing/Transitional Care facilities, (ii) 90 Senior Housing communities (?Senior Housing – Leased?), (iii) 23 Senior Housing communities operated by third-party property managers pursuant to property management agreements (?Senior Housing – Managed?) and (iv) 22 Specialty Hospitals and Other facilities), one investment in a direct financing lease, 22 investments in loans receivable (consisting of (i) one mortgage loan, (ii) two construction loans, (iii) one mezzanine loan and (iv) 18 other loans), nine preferred equity investments and one investment in an unconsolidated joint venture that owns 172 Senior Housing – Managed communities.

Featured Article: Marijuana Stocks Future Looks Bright

Want to see what other hedge funds are holding SBRA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Sabra Health Care REIT Inc (NASDAQ:SBRA).

Institutional Ownership by Quarter for Sabra Health Care REIT (NASDAQ:SBRA)

Receive News & Ratings for Sabra Health Care REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sabra Health Care REIT and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Armada Hoffler Properties  & Nam Tai Property  Head-To-Head Review
Armada Hoffler Properties & Nam Tai Property Head-To-Head Review
Critical Comparison: Taro Pharmaceutical Industries  and Genmab A/S
Critical Comparison: Taro Pharmaceutical Industries and Genmab A/S
Critical Comparison: Jerash Holdings   versus Its Rivals
Critical Comparison: Jerash Holdings versus Its Rivals
Comparing Symantec  & Tyler Technologies
Comparing Symantec & Tyler Technologies
LegacyTexas Financial Group  Raised to Buy at BidaskClub
LegacyTexas Financial Group Raised to Buy at BidaskClub
Adverum Biotechnologies  PT Lowered to $8.00 at SunTrust Banks
Adverum Biotechnologies PT Lowered to $8.00 at SunTrust Banks


 
© 2006-2019 Zolmax.